Padgett Medical Center Ocala

Lab Testing

Lab Tests to Check on GLP-1 Weight Loss Medication

Updated November 18, 2026 · 7 min read

The labs that matter on a GLP-1 weight-loss plan fall into four groups: blood sugar (A1C and C-peptide), cholesterol with ApoB, liver tests and kidney tests. The prescribing information for approved semaglutide and tirzepatide products calls for blood sugar checks in people with diabetes, and kidney checks when stomach side effects could lead to dehydration.

At Padgett, those tests come together in the GLP & Cardio Panel, a 24-test kit you collect at home. It is designed for patients on personalized compounded semaglutide or personalized compounded tirzepatide, and for anyone focused on heart and metabolic health. Which tests you need, and when, is your provider's call.

Why would a provider check labs on a GLP-1?

For a baseline, and to keep an eye on conditions that often travel with extra weight. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) lists overweight and obesity among the risk factors for insulin resistance and prediabetes, and links those conditions to unhealthy cholesterol and triglyceride levels and to fatty liver disease. MedlinePlus lists obesity, diabetes and high blood pressure among the things that raise the risk of kidney disease.

The medicines' labels add a second reason. The prescribing information for approved semaglutide and tirzepatide products warns about low blood sugar in some patients, kidney injury linked to dehydration, and gallbladder problems. Blood sugar and kidney tests speak directly to the first two. A result from before or early in treatment also gives your provider something to compare later results with.

What do A1C and C-peptide show?

A1C shows your average blood glucose over about the past three months, NIDDK says, and the panel also reports estimated average glucose, a figure calculated from the A1C. What your hemoglobin A1C test shows covers how the test works and the cut-offs health agencies publish.

C-peptide is a different kind of measure. MedlinePlus explains that the pancreas releases C-peptide and insulin into the blood at the same time and in equal amounts, and that C-peptide stays in the blood longer. Outside sources of insulin don't affect it, so it reflects the insulin your own body makes. Providers use it to help guide diabetes treatment and, when a diagnosis is uncertain, to help tell type 1 from type 2 diabetes.

Blood sugar matters on a GLP-1 because these medicines lower it. The labels for both approved products say they can cause low blood sugar (hypoglycemia), that the risk can be higher alongside insulin or an insulin secretagogue such as a sulfonylurea, a type of diabetes pill, and that people with diabetes should have their blood glucose checked before and during treatment. Make sure your provider knows about every diabetes medicine you take.

Why check cholesterol, ApoB and hs-CRP?

Because blood fats are among the problems that travel with insulin resistance. NIDDK says blood fats can rise with insulin resistance or prediabetes, and that health care professionals may recommend cholesterol and triglyceride tests.

The panel's lipid section goes further than a basic cholesterol test. It reports total, HDL, LDL (calculated) and VLDL cholesterol, triglycerides and apolipoprotein B (ApoB), plus two ratios: LDL-C to ApoB and LDL-C to HDL-C. What an ApoB blood test is explains why ApoB is on it. The panel also includes hs-CRP, a marker of inflammation covered in hs-CRP: what the inflammation blood test tells you.

Why do liver tests matter on a GLP-1?

NIDDK links fatty liver disease to insulin resistance, and MedlinePlus notes that people with risk factors such as obesity or diabetes may have liver tests. The panel's liver section includes ALT, AST and their ratio, GGT, ALP, direct bilirubin and total protein. MedlinePlus explains that ALT, AST, ALP and GGT are enzymes made mainly in the liver, that bilirubin is a waste product from breaking down old red blood cells which the liver mostly removes, and that total protein includes albumin and globulins, mainly made in the liver.

The labels add gallbladder disease. The prescribing information for both approved products reports more gallbladder disease in treated patients, such as gallstones or an inflamed gallbladder. The semaglutide label notes that substantial or rapid weight loss can raise the risk of gallstones, but that gallbladder disease was still more common on the medicine after accounting for weight loss. The same label lists liver test changes seen in its trials, and notes that in a trial in teenagers, some rises in the liver enzymes ALT and AST were tied to other factors, such as gallstones.

This panel is not a check for gallbladder disease or pancreatitis. The labels call for gallbladder studies when gallstones or gallbladder inflammation are suspected, and symptoms are the signal to act on. The Medication Guides ask patients to contact their provider about pain in the upper stomach, fever, yellow skin or eyes, or clay-colored stools, and to call right away about severe stomach pain that won't go away, with or without nausea or vomiting.

Why do kidney tests matter on a GLP-1?

Mainly because of dehydration. Both labels describe reports of kidney injury after the products reached the market, in some cases needing dialysis, under a warning about kidney injury from fluid loss. Their Medication Guides explain that diarrhea, nausea and vomiting can cause dehydration, which may cause kidney problems. The labels tell prescribers to monitor kidney function in patients with those side effects, especially when starting or raising a dose.

The panel's kidney section includes creatinine, BUN, their ratio and eGFR. MedlinePlus describes creatinine as a waste product from normal wear and tear on your muscles, and BUN as a waste product your kidneys remove from the blood. eGFR estimates how well your kidneys are working; it is calculated from creatinine along with age, weight, height and sex. MedlinePlus adds that eGFR isn't a perfect test, and that early kidney disease often has no symptoms.

Why is a thyroid test on a GLP-1 panel?

The panel includes TSH, the usual first check of thyroid function. Thyroid blood tests explained covers what it measures, and thyroid and weight gain looks at how much a slow thyroid can explain.

TSH is not a screen for the thyroid tumor warning on the approved products' labels. Those labels warn of a possible risk of thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), and say the medicines must not be used by people with a personal or family history of MTC or with multiple endocrine neoplasia syndrome type 2. They also say routine monitoring with calcitonin blood tests or thyroid ultrasound is of uncertain value for early detection. Their Medication Guides ask you to tell your provider about a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath.

What exactly is on the GLP & Cardio Panel?

Twenty-four tests in six groups. Cholesterol: total, HDL, LDL (calculated), VLDL, triglycerides, ApoB, the LDL-C : ApoB ratio and the LDL-C : HDL-C ratio. Blood sugar: hemoglobin A1C, estimated average glucose and C-peptide. Inflammation: hs-CRP. Thyroid: TSH. Liver: ALT, AST, the AST : ALT ratio, GGT, ALP, direct bilirubin and total protein. Kidneys: creatinine, BUN, the BUN : creatinine ratio and eGFR.

It does not include amylase or lipase, two pancreatic enzymes. The labels report that both rise on average during treatment, and say the meaning of those rises is unknown without signs of pancreatitis. Your provider decides which tests you need and how often; nothing in this article is a testing schedule to follow.

How do weight loss and lab orders work at Padgett in Ocala?

Padgett's program uses weekly injections of personalized compounded semaglutide or personalized compounded tirzepatide, medically supervised, in person in Ocala or by telehealth anywhere in Florida while you're physically in the state. Visits are with Sarah Weir, APRN, and your dose is personalized and adjusted with your provider over time. Personalized compounded semaglutide starts at $149 a month and personalized compounded tirzepatide at $229 a month, at the starting dose.

Lab panels are ordered through the at-home bloodwork store, online on each panel's page or by phone at (352) 369-0104. Panels start at $299. Online orders take 10% off, for online prices from $269.10, while phone orders are at the full list price. Prices subject to change. Kits go to Florida addresses only, for adults 18 and over.

You collect the sample at home with a simple device on your upper arm, in minutes, with no needle draw, no finger-prick and no lab visit. The sample goes back to the lab, and you go over the results with the Padgett team and decide on next steps. Ready to start a plan? Book a weight-loss visit online, or order the GLP & Cardio Panel first.

Personalized compounded semaglutide and personalized compounded tirzepatide are compounded drugs that have not been approved by the FDA. They have not been reviewed by the FDA for safety, effectiveness, or quality. FDA-approved products containing semaglutide and tirzepatide are available. Individual results vary.

This article is educational and is not medical advice. Talk with a licensed provider about your own health, medications and treatment options.

Pending medical review. This article is educational and is not medical advice. Never start, stop, split or change the timing of a prescription based on something you read online. Your provider decides your dose and your schedule.

Frequently asked questions

Can GLP-1 side effects show up on kidney tests?

They can. The labels for the approved products explain that nausea, vomiting and diarrhea can cause dehydration, which may lead to kidney problems, so they call for kidney checks in patients with those side effects. Don't wait for a scheduled panel: tell your provider right away about stomach symptoms that won't go away.

Does a high liver enzyme on a GLP-1 mean liver damage?

Not necessarily. MedlinePlus says abnormal liver test results don't always mean a problem with your liver, and that a high ALP, for example, can come from bone disease. Your provider reads any result alongside your symptoms, history and medicines, and may repeat or add tests before drawing a conclusion.

Does a C-peptide test show whether I have diabetes?

No. MedlinePlus says a C-peptide test is not used to diagnose diabetes; blood glucose tests are. C-peptide shows how much insulin your pancreas is making. NIDDK describes A1C as one of the tests used to find prediabetes, and A1C is on the same panel, so the two are read together.

Can I order the GLP & Cardio Panel if I'm not on a GLP-1?

Yes. The panel is designed for patients on GLP-1 weight-loss medications and for anyone focused on heart and metabolic health. Any adult 18 or older with a Florida address can order it online on its page, at 10% off, or by phone at (352) 369-0104 at the full list price.

How often should labs be repeated on a GLP-1?

There is no single schedule for everyone. The labels tie kidney checks to side effects and blood glucose checks to diabetes, and your provider decides what else to repeat and when, based on your history, results and medicines. Never change your dose or schedule on your own because of a lab result.

Free consultation, zero pressure

Take the first step toward feeling your best

Run through a few quick questions and reserve your free consultation, in person in Ocala or by telehealth anywhere in Florida. Most visits land on the same or next business day.

  • Your goals reviewed by a real provider
  • A plan made for you, never cookie-cutter
  • Visit us in Ocala or go telehealth statewide
  • A warm, judgment-free team